Clinical Trial Update: The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety of different dose levels of zidovudine in HIV-infected children has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED